Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

IL-17A is functionally relevant and a potential therapeutic target in bullous pemphigoid.

Journal of autoimmunity - 1 Jan 2019

Chakievska Lenche, Holtsche Maike M, Künstner Axel, Goletz Stephanie, Petersen Britt-Sabina, Thaci Diamant, Ibrahim Saleh M, Ludwig Ralf J, Franke Andre, Sadik Christian D, Zillikens Detlef, Hölscher Christoph, Busch Hauke, Schmidt Enno

Abstract excerpt

IL-17A has been identified as key regulatory molecule in several autoimmune and chronic inflammatory diseases followed by the successful use of anti-IL-17 therapy, e.g. in ankylosing spondylitis and psoriasis. Bullous pemphigoid (BP) is the most frequent autoimmune blistering disease with a high need for more specific, effective and safe treatment options. The aim of this study was to clarify the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Autoantibodies
Share to CD4-Positive T-Lymphocytes

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Exome Sequencing

Share to Interleukin-17

Share to Neutrophil Activation

Share to Neutrophils

Share to Pemphigoid, Bullous

Source

Identifiers

PMID: 30219389
DOI: 10.1016/j.jaut.2018.09.003

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

IL-17A is functionally relevant and a potential therapeutic target in bullous pemphigoid.PMID 30219389Read ↗

IL-17 in the Pathogenesis of Disease: Good Intentions Gone AwrySemantic proximity Read ↗

TH17/IL23 cytokine gene polymorphisms in bullous pemphigoid.Semantic proximity Read ↗

The IL-17 family in diseases: from bench to bedsideSemantic proximity Read ↗

Contribution of the IL-17 Pathway to Psoriasis and Psoriatic Arthritis.Semantic proximity Read ↗

Bullous pemphigoid: etiology, pathogenesis, and inducing factors: facts and controversies.Semantic proximity Read ↗

Bullous pemphigoid induced by dipeptidyl peptidase-4 inhibitors. Eight cases with clinical and immunological characterization.Semantic proximity Read ↗

The psoriasis-associated IL-17A induces and cooperates with IL-36 cytokines to control keratinocyte differentiation and functionSemantic proximity Read ↗

The interleukin-17 cytokine family: critical players in host defence and inflammatory diseasesSemantic proximity Read ↗

Association between TH2 Cytokine Gene Polymorphisms and Risk of Bullous Pemphigoid.Semantic proximity Read ↗

The function of interleukin 17 in the pathogenesis of rheumatoid arthritisSemantic proximity Read ↗

IL-17A plays a central role in the expression of psoriasis signature genes through the induction of IκB-ζ in keratinocytesSemantic proximity Read ↗

Cytokine profiling reveals HLA-linked Th2 and Th17 driven immune activation in pemphigus vulgaris patients and genetically susceptible healthy controls.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.